Medmix AGMDMXF 61 Gross Margin % is 35.67% as of Dec. 2025, which is 2% below its 10-year median of 36.45. GuruFocus rates MDMXF with a GF Score™ of 61/100 and a GF Value™ of $26.13. The stock has 7 warning signs investors should review. Among 2,999 Industrial Products companies, Medmix AG ranks better than 71.82% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Medmix AG's Gross Profit for the
six
months ended in Dec. 2025 was $99.6 Mil. Medmix AG's Revenue for the
six
months ended in Dec. 2025 was $279.3 Mil. Therefore, Medmix AG's Gross Margin % for the quarter that ended in Dec. 2025 was 35.67%.
Warning Sign:
Medmix AG gross margin has been in long-term decline. The average rate of decline per year is -1.3%.
The historical rank and industry rank for Medmix AG's Gross Margin % or its related term are showing as below:
MDMXF'
s Gross Margin % Range Over the Past 10 Years
Min: 32.39 Med: 36.45 Max: 39.62
Current: 36.14
During the past 8 years, the highestGross Margin % of Medmix AG was 39.62%. The lowest was 32.39%. And the median was 36.45%.
MDMXF's Gross Margin % is ranked better than 71.82% of 2999
companies
in the Industrial Products industry
Industry Median: 26.85
vs MDMXF: 36.14
Medmix AG had a gross margin of 35.67% for the quarter that ended in Dec. 2025 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Medmix AG was -1.30% per year.
Medmix AG (OTCPK:MDMXF) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Medmix AG had a gross margin of 35.67% for the quarter that ended in Dec. 2025 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Medmix AG Gross Margin % Related Terms
Medmix AG Gross Margin % Historical Data
* Premium members only.
The historical data trend for Medmix AG's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Industrial Machinery subindustry, Medmix AG's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medmix AG Gross Margin % vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Medmix AG's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Medmix AG's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Medmix AG (MDMXF) has a Gross Margin % of 35.67% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Medmix AG and its competitors. This is near median its historical median of 36.45. Over the past decade, Medmix AG's Gross Margin % has ranged from 32.39 to 39.62. According to the industry distribution chart, Medmix AG ranks #845 out of 2999 companies in the Industrial Products industry, placing it in the top 28.2%.
Is Medmix AG's Gross Margin % too high?
Medmix AG's current Gross Margin % of 35.67% is near median its 10-year median of 36.45. Over the past 10 years, this metric has ranged from a low of 32.39 to a high of 39.62. The Industrial Products industry median Gross Margin % is 26.85. Medmix AG's value of 35.67% is 32.8% above this industry median. Based on the distribution chart, Medmix AG ranks #845 out of 2999 companies in the Industrial Products industry, which is above the industry midpoint. Overall, Medmix AG has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does Medmix AG's Gross Margin % compare to GEV and ETN?
According to the Industrial Products industry distribution chart, Medmix AG ranks #845 out of 2999 companies for Gross Margin %. This puts Medmix AG in the upper half of its industry. The industry median Gross Margin % is 26.85. Medmix AG's value of 35.67% is 32.8% above this benchmark. Historically, Medmix AG's own Gross Margin % has ranged from 32.39 to 39.62 over the past decade. While the company's 10-year median is 36.45 vs. the industry median of 26.85, Medmix AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for an Industrial Products company?
The median Gross Margin % among Industrial Products companies is 26.85, based on 2,999 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medmix AG's current Gross Margin % of 35.67% is 32.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Medmix AG and its competitors. For the Industrial Products industry, the median Gross Margin % is 26.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medmix AG's current Gross Margin % is 35.67%, which is near median its own 10-year median of 36.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medmix AG stock overvalued right now?
Medmix AG (MDMXF) has a current Gross Margin % of 35.67%. The stock's GF Value™ is $26.13, compared to a current price of $17.40 — trading 33.4% below its estimated fair value. The current Gross Margin % is 35.67%, which is near median its 10-year median of 36.45 and 32.8% above the Industrial Products industry median of 26.85. Medmix AG's overall GF Score™ is 61/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Medmix AG (MDMXF), the current Gross Margin % is 35.67% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medmix AG (MDMXF) Overvalued in 2026?
Based on GuruFocus' analysis, Medmix AG stock appears to be undervalued.
The current stock price of $17.40 is trading 33.4% below its estimated GF Value™ of $26.13.
Key valuation signals for MDMXF:
Gross Margin %: 35.67% (near median its 10-year median of 36.45)
GF Value™: $26.13 vs. price of $17.40 (33.4% below fair value)
Industry Position: 32.8% above the Industrial Products median (#845 of 2999)
No single metric tells the full story. See the MDMXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medmix AG designs and produces high-precision delivery devices for the healthcare, consumer and industrial segments. Its segments are Healthcare, Consumer & Industrial, and Others. The Healthcare segment focuses on delivery devices for the drug delivery, surgery, and dental markets, including injection pens for subcutaneous drug delivery, surgical delivery devices, and mixing and delivery systems for the dental consumable industry. The Consumer & Industrial segment focuses on delivery devices used for industrial applications such as adhesives in construction, electronics, automotive, and aerospace, as well as consumer markets such as beauty and microbrush applications. The company operates in Europe, the Middle East and Africa, the Americas, and Asia-Pacific.
61GF Score
Get the complete analysis for MDMXF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDMXF has been successfully added to your 
